Dr. Jane Aubin Named New Chief Scientific Officer/Vice-President of Research at CIHR
The bone biologist and geneticist brings a wealth of knowledge as well as experience to her new post which begins on July 4
| For immediate release - | 2011-13 |
OTTAWA (June 15, 2011) – It is with great pleasure that the Canadian Institutes of Health Research (CIHR) announces the appointment of Dr. Jane Aubin to the position of Chief Scientific Officer/Vice-President, Research effective Monday, July 4, 2011. As Chief Scientific Officer, Dr. Aubin will assume responsibility for the oversight of all scientific affairs at CIHR and will provide CIHR with expert advice on matters relevant to science and technology, potential opportunities and emerging orientations and trends in the national and international health research community. As Vice-President, Research, she will also be responsible for all aspects of adjudication of Grants and Awards at CIHR and finally, as a member of the Scientific Council, she will participate in the development, implementation, and reporting on CIHR's research and knowledge translation strategy.
Dr. Aubin's career path has included several senior academic administrative positions, including Chair of the Graduate Department of Dentistry and Director of Postgraduate Dental Education and Chair of the Department of Anatomy and Cell Biology at the University of Toronto. She is currently a member of the Faculty of Medicine at the University of Toronto where she is a Professor of Molecular Genetics and the Director of the Bone Program in the Centre for Modeling Human Disease.
Dr. Aubin has been Scientific Director and CEO of the Canadian Arthritis Network of Centres of Excellence and, for the past 4 years, Scientific Director of CIHR's Institute of Musculoskeletal Health and Arthritis (IMHA). During her time as Scientific Director of IMHA, she has shown outstanding leadership qualities and an unwavering commitment to working with others to improve the health and quality of life of patients with arthritis, musculoskeletal, oral and skin conditions.
Dr. Aubin received a B.Sc. (Hons; Chemistry and Mathematics) and the Gold Medal in Chemistry at Queen's University in Kingston. She then completed her Ph.D. in Medical Biophysics at the University of Toronto. She later did her postdoctoral training in Molecular Biology and Biochemistry at the Max Planck Institute for Biophysical Chemistry in Goettingen, Germany.
-30-
About the Canadian Institutes of Health Research
The Canadian Institutes of Health Research (CIHR) is the Government of Canada's agency for health research. CIHR's mission is to create new scientific knowledge and to enable its translation into improved health, more effective health services and products, and a strengthened Canadian health-care system. Composed of 13 Institutes, CIHR provides leadership and support to more than 13,600 health researchers and trainees across Canada.
Media Contact:
David Coulombe
CIHR Media Specialist
Tel. (Office): 613-941-4563
Tel. (Mobile): 613-808-7526
Supplemental content (right column)
- Modified: